MONROVIA, Calif. (AP) — MONROVIA, Calif. (AP) — Xencor Inc. (XNCR) on Monday reported a loss of $60.8 million in its first quarter.
On a per-share basis, the Monrovia, California-based company said it had a loss of $1.02.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $19 million in the period, which beat Street forecasts. Five analysts surveyed by Zacks expected $18.8 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.